Stay updated with breaking news from Ma Jun. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
China’s National Medical Products Administration has approved 2 supplemental new drug applications of zanubrutinib for use in treatment-naïve adult patients with chronic lymphocytic leukemia or small lymphocytic lymphoma and Waldenström macroglobulinemia.
China’s National Medical Products Administration has approved 2 supplemental new drug applications of zanubrutinib for use in untreated adult patients with chronic lymphocytic leukemia or small lymphocytic lymphoma and Waldenström macroglobulinemia.
BRUKINSA is approved for first-line treatment for CLL/SLL and WM in China and has multiple approved indications in more than 65 markets worldwide BeiGene (NASDAQ: BGNE; HKEX: 06160; SSE: 688235),
BRUKINSA is approved for first-line treatment for CLL/SLL and WM in China and has multiple approved indications in more than 65 markets worldwide ... | May 6, 2023
China and Singapore have taken a bold step in forging a groundbreaking financing collaboration to create a more sustainable future. The two major Asian economies have established the China-Singapore Green Finance Taskforce (GFTF) to deepen bilateral cooperation in green and transition finance. The initiative aims to foster public-private sector collaboration and drive the transition to …<p class="read-more"> <a class="" href="https://www.cryptopolitan.com/china-and-singapore-financing-collaboration/"> <span class="screen-reader-text"...